Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 73, No 6 (2022)
Review paper
Submitted: 2022-03-01
Accepted: 2022-05-19
Published online: 2022-08-12
View PDF Download PDF file View HTML Supp./Additional Files [1]
Get Citation

Association of sleep duration and sleep quality with the risk of metabolic syndrome in adults: a systematic review and meta-analysis

Jingyao Hu1, Xiaoyue Zhu1, Defu Yuan1, Dakang Ji1, Haijian Guo2, You Li1, Zhiliang He1, Hexiang Bai1, Qiuqi Zhu1, Chenye Shen1, Haonan Ma1, Fangteng Fu1, Bei Wang1
DOI: 10.5603/EP.a2022.0058
·
Pubmed: 35971927
·
Endokrynol Pol 2022;73(6):968-987.
Affiliations
  1. Key Laboratory of Environment Medicine and Engineering of the Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, Jiangsu Province, China
  2. Integrated Business Management Office, Jiangsu Provincial Centre for Disease Control and Prevention, Nanjing, Jiangsu Province, China

open access

Vol 73, No 6 (2022)
Review Article
Submitted: 2022-03-01
Accepted: 2022-05-19
Published online: 2022-08-12

Abstract

Introduction: The association between sleep duration and metabolic syndrome (MetS) remains controversial, and few have considered the effects of sleep quality. We performed a meta-analysis to clarify the relationship of sleep duration and sleep quality with the risk of MetS.

Material and methods: We conducted a systematic and comprehensive literature search of electronic databases from inception to 17 February 2022. The effect sizes of covariates from each study were pooled using a random or fixed model, and a restricted cubic spline random-effects meta-analysis was performed to examine the dose-response relationship between sleep duration and MetS.

Results: A total of 62 studies were included in this meta-analysis. Compared to normal sleep duration, short sleep duration [odds ratio (OR) = 1.14, 95% confidence interval (CI): 1.10–1.19] and long sleep duration (OR = 1.15, 95% CI: 1.09–1.23) were associated with an increased risk of MetS. The restricted cubic spline analysis indicated that sleep durations of 8.5 h (OR = 0.95, 95% CI: 0.92–0.97) and 11 h (OR = 1.58, 95% CI: 1.31–1.91) were significantly associated with the risk of MetS. The pooled results showed that poor sleep quality (OR = 1.46, 95% CI: 1.03–2.06) and sleep complaints had significant positive associations with MetS.

Conclusion: Our results demonstrated that short sleep duration increased the risk of developing MetS. Long sleep duration was also associated with MetS, especially for 11 h. 8.5 h can be considered the recommended sleep duration for MetS. Poor sleep quality and sleep complaints were also associated with MetS.

Abstract

Introduction: The association between sleep duration and metabolic syndrome (MetS) remains controversial, and few have considered the effects of sleep quality. We performed a meta-analysis to clarify the relationship of sleep duration and sleep quality with the risk of MetS.

Material and methods: We conducted a systematic and comprehensive literature search of electronic databases from inception to 17 February 2022. The effect sizes of covariates from each study were pooled using a random or fixed model, and a restricted cubic spline random-effects meta-analysis was performed to examine the dose-response relationship between sleep duration and MetS.

Results: A total of 62 studies were included in this meta-analysis. Compared to normal sleep duration, short sleep duration [odds ratio (OR) = 1.14, 95% confidence interval (CI): 1.10–1.19] and long sleep duration (OR = 1.15, 95% CI: 1.09–1.23) were associated with an increased risk of MetS. The restricted cubic spline analysis indicated that sleep durations of 8.5 h (OR = 0.95, 95% CI: 0.92–0.97) and 11 h (OR = 1.58, 95% CI: 1.31–1.91) were significantly associated with the risk of MetS. The pooled results showed that poor sleep quality (OR = 1.46, 95% CI: 1.03–2.06) and sleep complaints had significant positive associations with MetS.

Conclusion: Our results demonstrated that short sleep duration increased the risk of developing MetS. Long sleep duration was also associated with MetS, especially for 11 h. 8.5 h can be considered the recommended sleep duration for MetS. Poor sleep quality and sleep complaints were also associated with MetS.

Full Text:

View PDF Download PDF file View HTML Supp./Additional Files [1]
Get Citation

Keywords

sleep duration; sleep quality; metabolic syndrome; meta-analysis

Supp./Additional Files (1)
Untitled
Download
141KB
About this article
Title

Association of sleep duration and sleep quality with the risk of metabolic syndrome in adults: a systematic review and meta-analysis

Journal

Endokrynologia Polska

Issue

Vol 73, No 6 (2022)

Article type

Review paper

Pages

968-987

Published online

2022-08-12

Page views

4345

Article views/downloads

726

DOI

10.5603/EP.a2022.0058

Pubmed

35971927

Bibliographic record

Endokrynol Pol 2022;73(6):968-987.

Keywords

sleep duration
sleep quality
metabolic syndrome
meta-analysis

Authors

Jingyao Hu
Xiaoyue Zhu
Defu Yuan
Dakang Ji
Haijian Guo
You Li
Zhiliang He
Hexiang Bai
Qiuqi Zhu
Chenye Shen
Haonan Ma
Fangteng Fu
Bei Wang

References (127)
  1. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28(4): 629–636.
    CrossRefPubMed
  2. Kim CJ, Park J, Kang SW. Prevalence of metabolic syndrome and cardiovascular risk level in a vulnerable population. Int J Nurs Pract. 2015; 21(2): 175–183.
    CrossRefPubMed
  3. Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, et al. RIVANA Study Investigators. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020; 19(1): 195.
    CrossRefPubMed
  4. Dibaba DT, Ogunsina K, Braithwaite D, et al. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype. Breast Cancer Res Treat. 2019; 174(1): 209–218.
    CrossRefPubMed
  5. Gacci M, Russo GI, De Nunzio C, et al. Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis. 2017; 20(2): 146–155.
    CrossRefPubMed
  6. O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015; 16(1): 1–12.
    CrossRefPubMed
  7. Hirode G, Wong RJ. Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. JAMA. 2020; 323(24): 2526–2528.
    CrossRefPubMed
  8. Lu J, Wang L, Li M, et al. 2010 China Noncommunicable Disease Surveillance Group. Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance. J Clin Endocrinol Metab. 2017; 102(2): 507–515.
    CrossRefPubMed
  9. Reutrakul S, Van Cauter E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018; 84: 56–66.
    CrossRefPubMed
  10. Lao XQ, Liu X, Deng HB, et al. Sleep Quality, Sleep Duration, and the Risk of Coronary Heart Disease: A Prospective Cohort Study With 60,586 Adults. J Clin Sleep Med. 2018; 14(1): 109–117.
    CrossRefPubMed
  11. Buysse DJ. Sleep health: can we define it? Does it matter? Sleep. 2014; 37(1): 9–17.
    CrossRefPubMed
  12. Chien KL, Chen PC, Hsu HC, et al. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Sleep. 2010; 33(2): 177–184.
    CrossRefPubMed
  13. Rod NH, Kumari M, Lange T, et al. The joint effect of sleep duration and disturbed sleep on cause-specific mortality: results from the Whitehall II cohort study. PLoS One. 2014; 9(4): e91965.
    CrossRefPubMed
  14. Beccuti G, Pannain S. Sleep and obesity. Curr Opin Clin Nutr Metab Care. 2011; 14(4): 402–412.
    CrossRefPubMed
  15. Cappuccio FP, D'Elia L, Strazzullo P, et al. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010; 33(2): 414–420.
    CrossRefPubMed
  16. St-Onge MP, Grandner MA, Brown D, et al. American Heart Association Obesity, Behavior Change, Diabetes, and Nutrition Committees of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2016; 134(18): e367–e386.
    CrossRefPubMed
  17. Kwok CS, Kontopantelis E, Kuligowski G, et al. Self-Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose-Response Meta-Analysis. J Am Heart Assoc. 2018; 7(15): e008552.
    CrossRefPubMed
  18. Xie J, Li Y, Zhang Y, et al. Sleep duration and metabolic syndrome: An updated systematic review and meta-analysis. Sleep Med Rev. 2021; 59: 101451.
    CrossRefPubMed
  19. Xi Bo, He D, Zhang M, et al. Short sleep duration predicts risk of metabolic syndrome: a systematic review and meta-analysis. Sleep Med Rev. 2014; 18(4): 293–297.
    CrossRefPubMed
  20. Iftikhar IH, Donley MA, Mindel J, et al. Sleep Duration and Metabolic Syndrome. An Updated Dose-Risk Metaanalysis. Ann Am Thorac Soc. 2015; 12(9): 1364–1372.
    CrossRefPubMed
  21. Hua J, Jiang H, Wang H, et al. Sleep Duration and the Risk of Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis. Front Neurol. 2021; 12: 635564.
    CrossRefPubMed
  22. Ju SY, Choi WS. Sleep duration and metabolic syndrome in adult populations: a meta-analysis of observational studies. Nutr Diabetes. 2013; 3: e65.
    CrossRefPubMed
  23. Che T, Yan C, Tian D, et al. The Association Between Sleep and Metabolic Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021; 12: 773646.
    CrossRefPubMed
  24. Lian Y, Yuan Q, Wang G, et al. Association between sleep quality and metabolic syndrome: A systematic review and meta-analysis. Psychiatry Res. 2019; 274: 66–74.
    CrossRefPubMed
  25. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372: n71.
    CrossRefPubMed
  26. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9): 603–605.
    CrossRefPubMed
  27. Adenekan B, Pandey A, McKenzie S, et al. Sleep in America: role of racial/ethnic differences. Sleep Med Rev. 2013; 17(4): 255–262.
    CrossRefPubMed
  28. Hirshkowitz M, Whiton K, Albert SM, et al. National Sleep Foundation's updated sleep duration recommendations: final report. Sleep Health. 2015; 1(4): 233–243.
    CrossRefPubMed
  29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3): 177–188.
    CrossRefPubMed
  30. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4): 719–748.
    PubMed
  31. Begg C, Mazumdar M. Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics. 1994; 50(4): 1088.
    CrossRefPubMed
  32. Choi JK, Kim MY, Kim JK, et al. Association between short sleep duration and high incidence of metabolic syndrome in midlife women. Tohoku J Exp Med. 2011; 225(3): 187–193.
    CrossRefPubMed
  33. Kim JY, Yadav D, Ahn SV, et al. A prospective study of total sleep duration and incident metabolic syndrome: the ARIRANG study. Sleep Med. 2015; 16(12): 1511–1515.
    CrossRefPubMed
  34. Li X, Lin L, Lv L, et al. U-shaped relationships between sleep duration and metabolic syndrome and metabolic syndrome components in males: a prospective cohort study. Sleep Med. 2015; 16(8): 949–954.
    CrossRefPubMed
  35. Song Q, Liu X, Zhou W, et al. Changes in sleep duration and risk of metabolic syndrome: the Kailuan prospective study. Sci Rep. 2016; 6: 36861.
    CrossRefPubMed
  36. Itani O, Kaneita Y, Tokiya M, et al. Short sleep duration, shift work, and actual days taken off work are predictive life-style risk factors for new-onset metabolic syndrome: a seven-year cohort study of 40,000 male workers. Sleep Med. 2017; 39: 87–94.
    CrossRefPubMed
  37. Deng HB, Tam T, Zee BCY, et al. Short Sleep Duration Increases Metabolic Impact in Healthy Adults: A Population-Based Cohort Study. Sleep. 2017; 40(10).
    CrossRefPubMed
  38. Wang Y, Qian YX, Liu JH, et al. Longitudinal association between sleep and 5-year incident metabolic syndrome in older Chinese adults: a community-based cohort study. Sleep Med. 2021; 81: 1–7.
    CrossRefPubMed
  39. Santos AC, Ebrahim S, Barros H. Alcohol intake, smoking, sleeping hours, physical activity and the metabolic syndrome. Prev Med. 2007; 44(4): 328–334.
    CrossRefPubMed
  40. Choi KM, Lee JS, Park HS, et al. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes (Lond). 2008; 32(7): 1091–1097.
    CrossRefPubMed
  41. Hall MH, Muldoon MF, Jennings JR, et al. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep. 2008; 31(5): 635–643.
    CrossRefPubMed
  42. Kobayashi D, Takahashi O, Deshpande GA, et al. Relation between metabolic syndrome and sleep duration in Japan: a large scale cross-sectional study. Intern Med. 2011; 50(2): 103–107.
    CrossRefPubMed
  43. Najafian J, Toghianifar N, Mohammadifard N, et al. Association between sleep duration and metabolic syndrome in a population-based study: Isfahan Healthy Heart Program. J Res Med Sci. 2011; 16(16): 801–806.
    PubMed
  44. Arora T, Jiang CQ, Thomas GN, et al. Self-reported long total sleep duration is associated with metabolic syndrome: the Guangzhou Biobank Cohort Study. Diabetes Care. 2011; 34(10): 2317–2319.
    CrossRefPubMed
  45. McCanlies EC, Slaven JE, Smith LM, et al. Metabolic syndrome and sleep duration in police officers. Work. 2012; 43(2): 133–139.
    CrossRefPubMed
  46. Sabanayagam C, Zhang R, Shankar A. Markers of Sleep-Disordered Breathing and Metabolic Syndrome in a Multiethnic Sample of US Adults: Results from the National Health and Nutrition Examination Survey 2005-2008. Cardiol Res Pract. 2012; 2012: 630802.
    CrossRefPubMed
  47. Wu MC, Yang YC, Wu JS, et al. Short sleep duration associated with a higher prevalence of metabolic syndrome in an apparently healthy population. Prev Med. 2012; 55(4): 305–309.
    CrossRefPubMed
  48. Lee J, Choi YS, Jeong YJ, et al. Poor-quality sleep is associated with metabolic syndrome in Korean adults. Tohoku J Exp Med. 2013; 231(4): 281–291.
    CrossRefPubMed
  49. Yoo H, Franke WD. Sleep habits, mental health, and the metabolic syndrome in law enforcement officers. J Occup Environ Med. 2013; 55(1): 99–103.
    CrossRefPubMed
  50. Chaput JP, McNeil J, Després JP, et al. Seven to eight hours of sleep a night is associated with a lower prevalence of the metabolic syndrome and reduced overall cardiometabolic risk in adults. PLoS One. 2013; 8(9): e72832.
    CrossRefPubMed
  51. Stefani KM, Kim HC, Kim J, et al. The influence of sex and age on the relationship between sleep duration and metabolic syndrome in Korean adults. Diabetes Res Clin Pract. 2013; 102(3): 250–259.
    CrossRefPubMed
  52. Ikeda M, Kaneita Y, Uchiyama M, et al. Epidemiological study of the associations between sleep complaints and metabolic syndrome in Japan. Sleep Biol Rhythms. 2014; 12(4): 269–278.
    CrossRef
  53. Yu S, Guo X, Yang H, et al. An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China. BMC Public Health. 2014; 14: 877.
    CrossRefPubMed
  54. Saleh D, Janssen I. Interrelationships among sedentary time, sleep duration, and the metabolic syndrome in adults. BMC Public Health. 2014; 14: 666.
    CrossRefPubMed
  55. Okubo N, Matsuzaka M, Takahashi I, et al. Hirosaki University Graduate School of Medicine. Relationship between self-reported sleep quality and metabolic syndrome in general population. BMC Public Health. 2014; 14: 562.
    CrossRefPubMed
  56. Chang JH, Huang PT, Lin YK, et al. Association between sleep duration and sleep quality, and metabolic syndrome in Taiwanese police officers. Int J Occup Med Environ Health. 2015; 28(6): 1011–1023.
    CrossRefPubMed
  57. Canuto R, Pattussi MP, Macagnan JB, et al. Metabolic syndrome in fixed-shift workers. Rev Saude Publica. 2015; 49: 30.
    CrossRefPubMed
  58. Wu J, Xu G, Shen L, et al. Daily sleep duration and risk of metabolic syndrome among middle-aged and older Chinese adults: cross-sectional evidence from the Dongfeng-Tongji cohort study. BMC Public Health. 2015; 15: 178.
    CrossRefPubMed
  59. Haba-Rubio J, Marques-Vidal P, Andries D, et al. Objective sleep structure and cardiovascular risk factors in the general population: the HypnoLaus Study. Sleep. 2015; 38(3): 391–400.
    CrossRefPubMed
  60. Lim W, So WY. Lifestyle-related factors and their association with metabolic syndrome in Korean adults: a population-based study. J Phys Ther Sci. 2015; 27(3): 555–558.
    CrossRefPubMed
  61. Xiao J, Shen C, Chu MJ, et al. Physical Activity and Sedentary Behavior Associated with Components of Metabolic Syndrome among People in Rural China. PLoS One. 2016; 11(1): e0147062.
    CrossRefPubMed
  62. Min H, Um YJ, Jang BS, et al. Association between Sleep Duration and Measurable Cardiometabolic Risk Factors in Healthy Korean Women: The Fourth and Fifth Korean National Health and Nutrition Examination Surveys (KNHANES IV and V). Int J Endocrinol. 2016; 2016: 3784210.
    CrossRefPubMed
  63. Lin SC, Sun CA, You SL, et al. The Link of Self-Reported Insomnia Symptoms and Sleep Duration with Metabolic Syndrome: A Chinese Population-Based Study. Sleep. 2016; 39(6): 1261–1266.
    CrossRefPubMed
  64. Rao DP, Orpana H, Krewski D. Physical activity and non-movement behaviours: their independent and combined associations with metabolic syndrome. Int J Behav Nutr Phys Act. 2016; 13: 26.
    CrossRefPubMed
  65. Yoon HS, Lee KM, Yang J, et al. Associations of sleep duration with metabolic syndrome and its components in adult Koreans: from the Health Examinees Study. Sleep Biol Rhythms. 2016; 14(4): 361–368.
    CrossRef
  66. Cole HV, Owusu-Dabo E, Iwelunmor J, et al. Sleep duration is associated with increased risk for cardiovascular outcomes: a pilot study in a sample of community dwelling adults in Ghana. Sleep Med. 2017; 34: 118–125.
    CrossRefPubMed
  67. Suliga E, Kozieł D, Cieśla E, et al. Sleep duration and the risk of metabolic syndrome — a cross-sectional study. Medical Studies. 2017; 3: 169–175.
    CrossRef
  68. Zohal M, Ghorbani A, Esmailzadehha N, et al. Association of sleep quality components and wake time with metabolic syndrome: The Qazvin Metabolic Diseases Study (QMDS), Iran. Diabetes Metab Syndr. 2017; 11 Suppl 1: S377–S380.
    CrossRefPubMed
  69. Kim CE, Shin S, Lee HW, et al. Association between sleep duration and metabolic syndrome: a cross-sectional study. BMC Public Health. 2018; 18(1): 720.
    CrossRefPubMed
  70. van der Pal KC, Koopman ADM, Lakerveld J, et al. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: the New Hoorn study. Sleep Med. 2018; 52: 51–57.
    CrossRefPubMed
  71. Titova OE, Lindberg E, Elmståhl S, et al. Associations Between the Prevalence of Metabolic Syndrome and Sleep Parameters Vary by Age. Front Endocrinol (Lausanne). 2018; 9: 234.
    CrossRefPubMed
  72. Ostadrahimi A, Nikniaz Z, Faramarzi E, et al. Does long sleep duration increase risk of metabolic syndrome in Azar cohort study population? Health Promot Perspect. 2018; 8(4): 290–295.
    CrossRefPubMed
  73. Kim KY, Yun JM. Analysis of the association between health-related and work-related factors among workers and metabolic syndrome using data from the Korean National Health and Nutrition Examination Survey (2016). Nutr Res Pract. 2019; 13(5): 444–451.
    CrossRefPubMed
  74. Qian YX, Liu JH, Ma QH, et al. Associations of sleep durations and sleep-related parameters with metabolic syndrome among older Chinese adults. Endocrine. 2019; 66(2): 240–248.
    CrossRefPubMed
  75. Gaston SA, Park YM, McWhorter KL, et al. Multiple poor sleep characteristics and metabolic abnormalities consistent with metabolic syndrome among white, black, and Hispanic/Latina women: modification by menopausal status. Diabetol Metab Syndr. 2019; 11: 17.
    CrossRefPubMed
  76. Fan L, Hao Z, Gao Li, et al. Non-linear relationship between sleep duration and metabolic syndrome: A population-based study. Medicine (Baltimore). 2020; 99(2): e18753.
    CrossRefPubMed
  77. Xu T, Zhu G, Han S. Prevalence of and lifestyle factors associated with metabolic syndrome determined using multi-level models in Chinese adults from a cross-sectional survey. Medicine (Baltimore). 2020; 99(44): e22883.
    CrossRefPubMed
  78. Lu K, Zhao Y, Chen J, et al. Interactive association of sleep duration and sleep quality with the prevalence of metabolic syndrome in adult Chinese males. Exp Ther Med. 2020; 19(2): 841–848.
    CrossRefPubMed
  79. Ghazizadeh H, Mobarra N, Esmaily H, et al. The association between daily naps and metabolic syndrome: Evidence from a population-based study in the Middle-East. Sleep Health. 2020; 6(5): 684–689.
    CrossRefPubMed
  80. Wang MH, Shi T, Li Q, et al. Associations of sleep duration and fruit and vegetable intake with the risk of metabolic syndrome in Chinese adults. Medicine (Baltimore). 2021; 100(10): e24600.
    CrossRefPubMed
  81. Aryannejad A, Eghtesad S, Rahimi Z, et al. Metabolic syndrome and lifestyle-associated factors in the ethnically diverse population of Khuzestan, Iran: a cross-sectional study. J Diabetes Metab Disord. 2021; 20(1): 747–756.
    CrossRefPubMed
  82. Li W, Kondracki AJ, Sun N, et al. Nighttime sleep duration, daytime napping, and metabolic syndrome: findings from the China Health and Retirement Longitudinal Study. Sleep Breath. 2021 [Epub ahead of print].
    CrossRefPubMed
  83. Feng X, Wu W, Zhao F, et al. Relationship between self-reported sleep duration during week-/work-days and metabolic syndrome from NHANES 2013 to 2016. Sleep Breath. 2021 [Epub ahead of print].
    CrossRefPubMed
  84. Katsuura-Kamano S, Arisawa K, Uemura H, et al. Japan Multi-Institutional Collaborative Cohort J-MICC Study. Association of skipping breakfast and short sleep duration with the prevalence of metabolic syndrome in the general Japanese population: Baseline data from the Japan Multi-Institutional Collaborative cohort study. Prev Med Rep. 2021; 24: 101613.
    CrossRefPubMed
  85. Buysse D, Reynolds C, Monk T, et al. The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2): 193–213.
    CrossRefPubMed
  86. Itani O, Jike M, Watanabe N, et al. Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Med. 2017; 32: 246–256.
    CrossRefPubMed
  87. Johnson KA, Gordon CJ, Chapman JL, et al. The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysis. Sleep Med Rev. 2021; 59: 101456.
    CrossRefPubMed
  88. Wang Y, Mei H, Jiang YR, et al. Relationship between Duration of Sleep and Hypertension in Adults: A Meta-Analysis. J Clin Sleep Med. 2015; 11(9): 1047–1056.
    CrossRefPubMed
  89. Zhou Q, Zhang M, Hu D. Dose-response association between sleep duration and obesity risk: a systematic review and meta-analysis of prospective cohort studies. Sleep Breath. 2019; 23(4): 1035–1045.
    CrossRefPubMed
  90. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004; 1(3): e62.
    CrossRefPubMed
  91. Spiegel K, Tasali E, Penev P, et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004; 141(11): 846–850.
    CrossRefPubMed
  92. Chaput JP, Després JP, Bouchard C, et al. Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring). 2007; 15(1): 253–261.
    CrossRefPubMed
  93. Spiegel K, Knutson K, Leproult R, et al. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol (1985). 2005; 99(5): 2008–2019.
    CrossRefPubMed
  94. Spiegel K, Leproult R, Cauter EV. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999; 354(9188): 1435–1439.
    CrossRefPubMed
  95. Wright KP, Drake AL, Frey DJ, et al. Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance. Brain Behav Immun. 2015; 47: 24–34.
    CrossRefPubMed
  96. Vgontzas AN, Zoumakis E, Bixler EO, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004; 89(5): 2119–2126.
    CrossRefPubMed
  97. Irwin MR, Witarama T, Caudill M, et al. Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav Immun. 2015; 47: 86–92.
    CrossRefPubMed
  98. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004; 43(4): 678–683.
    CrossRefPubMed
  99. Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016; 80(1): 40–52.
    CrossRefPubMed
  100. Tobaldini E, Costantino G, Solbiati M, et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev. 2017; 74(Pt B): 321–329.
    CrossRefPubMed
  101. Pongratz G, Straub RH. The sympathetic nervous response in inflammation. Arthritis Res Ther. 2014; 16(6): 504.
    CrossRefPubMed
  102. Sun X, Zheng B, Lv J, et al. China Kadoorie Biobank (CKB) Collaborative Group. Sleep behavior and depression: Findings from the China Kadoorie Biobank of 0.5 million Chinese adults. J Affect Disord. 2018; 229: 120–124.
    CrossRefPubMed
  103. Zhai L, Zhang H, Zhang D. Sleep duration and depression among adults：A meta-analysis of prospective studies. Depress Anxiety. 2015; 32(9): 664–670.
    CrossRefPubMed
  104. Pan An, Keum N, Okereke OI, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012; 35(5): 1171–1180.
    CrossRefPubMed
  105. Grandner MA, Drummond SPA. Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev. 2007; 11(5): 341–360.
    CrossRefPubMed
  106. Williams CJ, Hu FB, Patel SR, et al. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007; 30(5): 1233–1240.
    CrossRefPubMed
  107. Patel SR, Zhu X, Storfer-Isser A, et al. Sleep duration and biomarkers of inflammation. Sleep. 2009; 32(2): 200–204.
    CrossRefPubMed
  108. Beaman A, Bhide MC, McHill AW, et al. Biological pathways underlying the association between habitual long-sleep and elevated cardiovascular risk in adults. Sleep Med. 2021; 78: 135–140.
    CrossRefPubMed
  109. Yan LX, Chen XR, Chen Bo, et al. Gender-specific Association of Sleep Duration with Body Mass Index, Waist Circumference, and Body Fat in Chinese Adults. Biomed Environ Sci. 2017; 30(3): 157–169.
    CrossRefPubMed
  110. Ozemek C, Lavie CJ, Rognmo Ø. Global physical activity levels - Need for intervention. Prog Cardiovasc Dis. 2019; 62(2): 102–107.
    CrossRefPubMed
  111. Leskinen T, Stenholm S, Heinonen OJ, et al. Change in physical activity and accumulation of cardiometabolic risk factors. Prev Med. 2018; 112: 31–37.
    CrossRefPubMed
  112. Shi JQ, Copas JB. Meta-analysis for trend estimation. Stat Med. 2004; 23(1): 3–19; discussion 159.
    CrossRefPubMed
  113. Hartemink N, Boshuizen HC, Nagelkerke NJD, et al. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol. 2006; 163(11): 1042–1052.
    CrossRefPubMed
  114. Tramunt B, Smati S, Grandgeorge N, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020; 63(3): 453–461.
    CrossRefPubMed
  115. Ancoli-Israel S, Cole R, Alessi C, et al. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003; 26(3): 342–392.
    CrossRefPubMed
  116. Wong PM, Manuck SB, DiNardo MM, et al. Shorter sleep duration is associated with decreased insulin sensitivity in healthy white men. Sleep. 2015; 38(2): 223–231.
    CrossRefPubMed
  117. Tobaldini E, Fiorelli EM, Solbiati M, et al. Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence. Nat Rev Cardiol. 2019; 16(4): 213–224.
    CrossRefPubMed
  118. Aziz M, Ali SS, Das S, et al. Association of Subjective and Objective Sleep Duration as well as Sleep Quality with Non-Invasive Markers of Sub-Clinical Cardiovascular Disease (CVD): A Systematic Review. J Atheroscler Thromb. 2017; 24(3): 208–226.
    CrossRefPubMed
  119. Sun J, Wang M, Yang L, et al. Sleep duration and cardiovascular risk factors in children and adolescents: A systematic review. Sleep Med Rev. 2020; 53: 101338.
    CrossRefPubMed
  120. Holzhausen EA, Hagen EW, LeCaire T, et al. A Comparison of Self- and Proxy-Reported Subjective Sleep Durations With Objective Actigraphy Measurements in a Survey of Wisconsin Children 6-17 Years of Age. Am J Epidemiol. 2021; 190(5): 755–765.
    CrossRefPubMed
  121. Lee SW, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis. Sleep Med Rev. 2017; 31: 91–101.
    CrossRefPubMed
  122. Quist JS, Sjödin A, Chaput JP, et al. Sleep and cardiometabolic risk in children and adolescents. Sleep Med Rev. 2016; 29: 76–100.
    CrossRefPubMed
  123. Morris CJ, Aeschbach D, Scheer FA. Circadian system, sleep and endocrinology. Mol Cell Endocrinol. 2012; 349(1): 91–104.
    CrossRefPubMed
  124. Dierickx P, Van Laake LW, Geijsen N. Circadian clocks: from stem cells to tissue homeostasis and regeneration. EMBO Rep. 2018; 19(1): 18–28.
    CrossRefPubMed
  125. Yamada T, Shojima N, Yamauchi T, et al. J-curve relation between daytime nap duration and type 2 diabetes or metabolic syndrome: A dose-response meta-analysis. Sci Rep. 2016; 6: 38075.
    CrossRefPubMed
  126. Pan W, Kastin AJ. Leptin: a biomarker for sleep disorders? Sleep Med Rev. 2014; 18(3): 283–290.
    CrossRefPubMed
  127. Castro-Diehl C, Diez Roux AV, Redline S, et al. Association of Sleep Duration and Quality With Alterations in the Hypothalamic-Pituitary Adrenocortical Axis: The Multi-Ethnic Study of Atherosclerosis (MESA). J Clin Endocrinol Metab. 2015; 100(8): 3149–3158.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl